Nitric oxide, the kidney and hypertension

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 8, 1997, Pages 600-606

  Schnackenberg, C ^a   Patel, A R ^b   Kirchner, K A ^b   Granger, J P ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Renal haemodynamics; Sodium excretion

Indexed keywords

N(G) NITROARGININE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DOG; HUMAN; HYPERTENSION; KIDNEY PERFUSION; NATRIURESIS; NONHUMAN; PERFUSION PRESSURE;

EID: 0030860361     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb02099.x     Document Type: Conference Paper

References (50)

1. Guyton AC. Renal function curve: A key to understanding the pathogenesis of hypertension. Hypertension 1987; 10: 1-6.
2. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P. Remission of essential hypertension after renal transplantation. N. Engl. J. Med. 1983; 309: 1009-15.
3. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
4. Ignarro LJ, Buga GM, Woods KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl Acad. Sci. USA 1987; 84: 9265-9.
5. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-6.
6. Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl Acad. Sci. USA 1989; 86: 3375-8.
7. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J. Clin. Invest. 1992; 90: 278-81.
8. Salazar FJ, Pinilla JM, Lïpez F, Romero JC, Quesada T. Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension 1992; 20: 113-17.
9. Salazar FJ, Alberola A, Pinilla JM, Romero JC, Quesada T. Salt-induced increase in arterial pressure during nitric oxide synthesis inhibition. Hypertension 1993; 22: 49-55.
10. Manning RD, Hu L. Nitric oxide regulates renal hemodynamics and urinary sodium excretion in dogs. Hypertension 1994; 23: 619-25.
11. Granger JP, Novak J, Schnackenberg C, Williams S, Reinhart G. Role of renal nerves in mediating the hypertensive effects of nitric oxide synthesis inhibition. Hypertension 1996; 27: 613-18.
12. Schultz, PJ, Tolins JP. Adaptation to increased dietary salt intake in the rat. J. Clin. Invest. 1993; 91: 642-50.
13. Luscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986; 8: 344-8.
14. Luscher TF, Raij L, Vanhoutte PM. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 1987; 9: 157-63.
15. Lockett W, Otsuka Y, Carretero O. The loss of endothelium-dependent vascular relaxation in hypertension. Hypertension 1986; 8 (Suppl. II): II-61-6.
16. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J. Clin. Invest. 1991; 88: 1559-67.
17. Patel A, Layne S, Watts D, Kirchner KA. L-Arginine administration normalizes pressure natriuresis in hypertensive Dahl rats. Hypertension 1993; 22: 863-9.
18. Sigmon DH, Beierwaltes WH. Nitric oxide influences blood flow distribution in renovascular hypertension. Hypertension 1994; 23 (Suppl. I): 1-34-9.
19. Kirchner KA, Scanlon PH, Dzielak DJ, Hester RL. Endothelial-derived relaxing factor responses in DOCA-salt hypertensive rats. Am. J. Physiol. 1993; 263: R568-72.
20. Hayakawa H, Hirata Y, Suzuki E et al. Long-term administration of L-arginine improves nitric oxide release from kidney in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 1994; 23: 752-6.
21. Salom MG, Lahera V, Miranda-Guardiola F, Romero JC. Blockade of pressure natriuresis induced by inhibition of renal synthesis of nitric oxide in dogs. Am. J. Physiol. 1992; 262: F718-22.
22. Majid DSA, Williams A, Kadowitz PJ, Navar LG. Renal responses to intra-arterial administration of nitric oxide donor in dogs. Hypertension 1993; 22: 535-41.
23. Baylis C, Harton P, Engels K. Endothelial-derived relaxing factor controls renal hemodynamics in the normal rat kidney. J. Am. Soc. Nephrol. 1990; 1: 875-81.
24. Deng A, Baylis C. Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am. J. Physiol. 1993; 264: F212-15.
25. Ito S, Johnson CS, Carretero OA. Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in isolated microperfused rabbit afferent arteriole. J. Clin. Invest. 1991; 87: 1656-63.
26. Imig JD, Roman RJ. Nitric oxide modulates vascular tone in preglomerular arterioles. Hypertension 1992; 19: 770-4.
27. Alberola A, Salazar FJ, Nakamura T, Granger JP. Renal hemodynamic effects of angiotensin II (AII): Interactions with endothelium derived nitric oxide. Am. J. Physiol. 1994; 267: R1472-8.
28. Ohishi K, Carmines PK, Inscho EW, Navar LG. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am. J. Physiol. 1992; 263: F900-6.
29. Sigmon DH, Carretero OA, Beierwaltes WH. Angiotensin dependence of endothelium-mediated renal hemodynamics. Hypertension 1992; 20: 643-50.
30. De Nicola L, Blantz RC, Gabbai FB. Nitric oxide and angiotensin II. J. Clin. Invest. 1992; 89: 1248-56.
31. Baylis C, Engels K, Samsell L, Harton P. Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II. Am. J. Physiol. 1993; 264: F74-8.
32. Sigmon DH, Newman JM, Beierwaltes WH. Angiotensin II: Endothelium-derived nitric oxide interaction in conscious rats. J. Am. Soc. Nephrol. 1994; 4: 1675-82.
33. G-Methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. Circ. Res. 1992; 70: 607-11.
34. Matsuoka H, Nishida H, Nomura G, Van Vliet BN, Toshima H. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension 1994; 23: 971-5.
35. Beierwaltes WH, Carretero OA. Nonprostanoid endothelium-derived factors inhibit renin release. Hypertension 1992; 19 (Suppl. 2): 268-73.
36. Sigmon DH, Carretero OA, Beierwaltes WH. Endothelium-derived relaxing factor regulates renin release in vivo. Am. J. Physiol. 1992; 263: F256-61.
37. Schnackenberg C, Wilkins C, Strong M, Granger JP. Intrarenal NO blockade enhances renin secretion rate by a macula densa mechanism. Am. J. Physiol. 1997; 272: R879-86.
38. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am. J. Physiol. 1991; 261: F1033-7.
39. Alberola A, Pinilla JM, Quesada T, Romero JC, Salom MG, Salazar FJ. Role of nitric oxide in mediating renal response to volume expansion. Hypertension 1992; 19: 780-4.
40. Lahera V, Navarro J, Biondi ML, Ruilope M, Romero JC. Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis. Am. J. Physiol. 1993; 264: F334-47.
41. Nakamura T, Alberola AM, Granger JP. Role of renal interstitial pressure as a mediator of sodium retention during systemic blockade of nitric oxide. Hypertension 1993; 21: 956-60.
42. Patel AR, Granger JP, Kirchner KA., L-Arginine improves transmission of perfusion pressure to the renal interstitium in Dahl salt-sensitive rats. Am. J. Physiol. 1994; 266: R1730-5.
43. Morrissey JJ, McCracken R, Kaneto H, Vehaskari M, Montani D, Klahr S. Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int. 1994; 45: 998-1005.
44. Biondi ML, Dousa T, Vanhoutte P, Romero JC. Evidences for the existence of endothelium-derived relaxing factor in the renal medulla. Am. J. Hypertens. 1990; 3: 876-8.
45. Mattson DL, Roman RJ, Cowley AW. Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension 1992; 19: 766-9.
46. Mattson DL, Lu S, Nakanishi K, Papanek PE, Cowley AW. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am. J. Physiol. 1994; 266: H1918-26.
47. Markewitz B, Michael J, Kohan D. Cytokine-induced expression of a nitric oxide synthase in rat renal tubule cells. J. Clin. Invest. 1993; 91: 2138-43.
48. Tracey WR, Pollock JS, Murad F, Nakane M, Forstermann U. Identification of an endothelial-like type III NO synthase in LLC-PK1 kidney epithelial cells. Am. J. Physiol. 1994; 266: C22-8.
49. Stoos BA, Carretero OA, Garvin JL. Endothelial-derived nitric oxide inhibits sodium transport by affecting apical membrane channels in cultured collecting duct cells. J. Am. Soc. Nephrol. 1994; 4: 1855-60.
50. Kirchner KA, Patel BA, Granger JP. Segmental chloride transport in the Dahl S rat kidney during L-arginine administration. J. Am. Soc. Nephrol. 1995; 5: 1567-72.